Showing results (1711-1720 of 2,952) with videos related to
Sort By:
Pageof 296
The Medical Journal of Australia|November 10, 2025
The first Australian evidence-based guidelines on male infertilityDarren J Katz, Liza O'Donnell, Robert I McLachlan, et al.Biorxiv : the Preprint Server for Biology|June 4, 2025
Role of channels in the O 2 permeability of murine red blood cells I. Stopped-flow and hematological studiesPan Zhao, Fraser J Moss, Rossana Occhipinti, et al.The American Journal of Cardiology|October 29, 2015
Effects of Statins on First and Recurrent Supraventricular Arrhythmias in Patients With Mild Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)Yitschak Biton, Ilan Goldenberg, Valentina Kutyifa, et al.The Journal of Biological Chemistry|April 15, 2022
Ammonia induces amyloidogenesis in astrocytes by promoting amyloid precursor protein translocation into the endoplasmic reticulumAyaka Komatsu, Izumi Iida, Yusuke Nasu, et al.Journal of Biopharmaceutical Statistics|March 15, 2003
Uising WinBUGS to fit nonlinear mixed models with an application to pharmacokinetic modelling of insulin response to glucose challenge in sheep exposed antenatally to glucocorticoidsLyle C Gurrin, Timothy J Moss, Deborah M Sloboda, et al.Heart Rhythm|March 29, 2017
Predictive value of device-derived activity level for short-term outcomes in MADIT-CRTSina Jamé, Valentina Kutyifa, Bronislava Polonsky, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2019
Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled AnalysisShaun A Truelove, Lindsay T Keegan, William J Moss, et al.Heart Rhythm|April 22, 2018
Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-DefibrillatorUsama A Daimee, Katherine Vermilye, Arthur J Moss, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activationD A Mitchell, P R Taylor, H T Cook, et al.Plos One|May 10, 2011
HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapyJanneke H van Dijk, Catherine G Sutcliffe, Bornface Munsanje, et al.Pageof 296